Benzinga

Elon Musk-Backed Brain Implant Firm Neuralink Starts Participant Enrollment In Brain Implant Human Trial For Paralysis

• Elon Musk's brain-computer interface company, Neuralink, has initiated recruiting its first test subjects for human trials aimed at assisting individuals with paralysis in controlling devices.
• Neuralink announced that it has obtained approval from an independent institutional review board and the initial hospital site, enabling the commencement of recruitment for its first-in-human clinical trial known as "The PRIME Study" (Precise Robotically Implanted Brain-Computer Interface).

FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray

• The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ:SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for adults and children ≥30 kg. 
• ARS Pharma's Neffy is to be an alternative to EpiPen and other autoinjectors like Sanofi SA's (NASDAQ: SNY) Auvi-Q filled with epinephrine.

Eli Lilly Cracks Down on Counterfeit Mounjaro Weight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics

• Eli Lilly And Co (NYSE:LLY) has taken legal action against ten entities in the U.S., including medical spas, wellness centers, and compounding pharmacies, alleging that they have been selling unauthorized, less expensive versions of its diabetes drug, Mounjaro (tirzepatide). 
• Eli Lilly has lodged four distinct lawsuits in federal courts in Florida and Texas. These lawsuits aim to obtain court orders that prevent Better Life Pharmacy, ReviveRX, Rx Compound Store, and Wells Pharmacy Network from marketing tirzepatide and seek unspecified monetary damages. 

Pillsbury Maker's Q1 Performance Exceeds Expectations, Anticipates Moderate Input Cost Inflation and Stable Supply Chain in 2024

• General Mills Inc (NYSE:GIS) reported first-quarter FY24 sales growth of 4% year-on-year to $4.90 billion, beating the analyst consensus of $4.88 billion. Adjusted EPS of $1.09 topped the consensus of $1.08. 
• Outlook: General Mills reaffirmed its FY24 organic sales growth outlook of 3% - 4%.

Boeing Pegs China 20-Year Demand Forecast To 8,560 New Planes Due To Robust Demand

• Boeing Co (NYSE:BA) has anticipated that China will require 8,560 new commercial airplanes through 2042.
• The company arrived at the figure considering the possible economic growth well above the global average and increasing demand for domestic air travel. 

Coty Raises FY24 Forecasts

• Following the sizzling debut of its Burberry Goddess scent and other blockbuster releases, Coty Inc (NYSE:COTY) has confidently amped up its FY24 forecasts.
• The company is now expecting core LFL sales growth in the first half of FY24 of +10-12% (prior view: +8-10%). 

Wall Street Journal

Tobacco Giant Philip Morris Rethinks Pharma Dive, Mulls Vectura Stake Sale Amid Challenges

• Philip Morris International Inc (NYSE:PM) is reportedly mulling to sell a stake in its U.K.-based Vectura pharmaceuticals unit.
• The tobacco company is searching for a new partner to make the business work, possibly by selling a majority or minority stake.

Goldman Sachs To Sell Consumer Lending Business GreenSky

Financial Times

WhatsApp's Payment Revolution: Meta Looks to Capitalize on India's In-App Payment Surge

Bloomberg

Antitrust Trial Exposes Google's Battle Against Amazon for Advertising Supremacy

Apple Workers in France Call for 7% Pay Hike, Strike Coincides with iPhone 15 Release

Ford Says UK Petrol-Car Ban Delay Could Risk EV Transition

Intel CEO Stresses Role in AI Boom, Taking on Nvidia in Accelerator Tech at Innovation Conference

Meta's Threads Censorship Raises Concerns About Real-Time Engagement And User Appeal

Reuters 

Huawei's HiSilicon Bypasses Export Controls, Posing Competition to Apple and Nvidia with Surveillance Chip Shipments

• In a notable development, a unit of Huawei Technologies Co, Ltd has begun shipping surveillance camera chips, signaling the company's ability to navigate around four years of stringent U.S. export controls. 
• These shipments from Huawei's HiSilicon chip design unit commenced this year, potentially impacting the market, with some of the customers being Chinese.

Qantas' Ex-CEO Takes 900% Salary Hike But Faces Bonus Reduction Due To Scandal

CNBC

Stock Trading Feature For iPhones? A Financial Service Apple And Goldman Sachs Almost Delivered

Pinterest Stock Rallies On Anticipated Accelerated Revenue Growth